- Home
- Publications
- Publication Search
- Publication Details
Title
Epigenetic regulation and targeting of ECM for cancer therapy
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
Volume 322, Issue 4, Pages C762-C768
Publisher
American Physiological Society
Online
2022-03-03
DOI
10.1152/ajpcell.00022.2022
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LOX-1 and cancer: an indissoluble liaison
- (2021) M. Murdocca et al. CANCER GENE THERAPY
- A Guide to the Composition and Functions of the Extracellular Matrix
- (2021) Nikos K. Karamanos et al. FEBS Journal
- Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer
- (2021) Alessandro De Vita et al. Scientific Reports
- Collagen XI alpha 1 chain, a potential therapeutic target for cancer
- (2021) Ziqiang Liu et al. FASEB JOURNAL
- Integrins as attractive targets for cancer therapeutics
- (2021) Meng Li et al. Acta Pharmaceutica Sinica B
- 5-aza-2′-deoxycitidine inhibits cell proliferation, extracellular matrix formation and Wnt/β-catenin pathway in human uterine leiomyomas
- (2021) María Cristina Carbajo-García et al. Reproductive Biology and Endocrinology
- Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment
- (2020) Yi-Hui Wu et al. Frontiers in Pharmacology
- 3D Extracellular Matrix Mimics: Fundamental Concepts and Role of Materials Chemistry to Influence Stem Cell Fate
- (2020) Julien Nicolas et al. BIOMACROMOLECULES
- Pancreatic cancer stroma: an update on therapeutic targeting strategies
- (2020) Abdel N. Hosein et al. Nature Reviews Gastroenterology & Hepatology
- Shaping Up the Tumor Microenvironment With Cellular Fibronectin
- (2020) Georgios Efthymiou et al. Frontiers in Oncology
- Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors
- (2020) Girieca Lorusso et al. Frontiers in Oncology
- Correlation of anti-tumour drug resistance with epigenetic regulation
- (2020) Takuma Hayashi et al. BRITISH JOURNAL OF CANCER
- Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
- (2019) Yanxia Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EMT is associated with an epigenetic signature of ECM remodeling genes
- (2019) Paul Peixoto et al. Cell Death & Disease
- Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression
- (2019) Yi-Hui Wu et al. Cell Death & Disease
- Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer
- (2019) Janet E. Murphy et al. JAMA Oncology
- Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis
- (2019) van Mackelenbergh et al. Cancers
- The Role of the Extracellular Matrix in Cancer Stemness
- (2019) Sameera Nallanthighal et al. Frontiers in Cell and Developmental Biology
- Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors
- (2019) Assaf Zinger et al. ACS Nano
- Targeting LOX-1 Inhibits Colorectal Cancer Metastasis in an Animal Model
- (2019) Michela Murdocca et al. Frontiers in Oncology
- Fighting against Skin Aging
- (2018) Shoubing Zhang et al. CELL TRANSPLANTATION
- Nanoparticle-based hyperthermia, a local treatment modulating the tumor extracellular matrix
- (2017) Jelena Kolosnjaj-Tabi et al. PHARMACOLOGICAL RESEARCH
- Epigenetic Modulation of Collagen 1A1: Therapeutic Implications in Fibrosis and Endometriosis1
- (2016) Ye Zheng et al. BIOLOGY OF REPRODUCTION
- Lysyl Oxidase, a Targetable Secreted Molecule Involved in Cancer Metastasis
- (2016) Thomas R. Cox et al. CANCER RESEARCH
- Epigenetic Determinants of Cancer
- (2016) Stephen B. Baylin et al. Cold Spring Harbor Perspectives in Biology
- Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
- (2015) Bryan W Miller et al. EMBO Molecular Medicine
- Novel patented therapeutic approaches targeting the 37/67 kDa laminin receptor for treatment of cancer and Alzheimer’s disease
- (2015) Katarina Jovanovic et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- A collagen-binding EGFR single-chain Fv antibody fragment for the targeted cancer therapy
- (2015) Hui Liang et al. JOURNAL OF CONTROLLED RELEASE
- Identification and characterization of a unique role for EDB fibronectin in phagocytosis
- (2015) Sabrina Kraft et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Knockdown of LRP/LR Induces Apoptosis in Breast and Oesophageal Cancer Cells
- (2015) Thandokuhle Khumalo et al. PLoS One
- Solanum Incanum Extract Downregulates Aldehyde Dehydrogenase 1-Mediated Stemness and Inhibits Tumor Formation in Ovarian Cancer Cells
- (2015) Yi-Hui Wu et al. Journal of Cancer
- The extracellular matrix modulates the hallmarks of cancer
- (2014) M. W. Pickup et al. EMBO REPORTS
- Illustrating the interplay between the extracellular matrix and microRNAs
- (2014) Anna M. Piccinini et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18
- (2013) Thandokuhle Khumalo et al. PLoS One
- Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer
- (2012) B. Besse et al. ANNALS OF ONCOLOGY
- Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA
- (2012) Simon Toupance et al. CLINICAL & EXPERIMENTAL METASTASIS
- miRNAs regulate expression and function of extracellular matrix molecules
- (2012) Zina Jeyapalan Rutnam et al. MATRIX BIOLOGY
- Integrin-epigenetics: a system with imperative impact on cancer
- (2011) Moonmoon Deb et al. CANCER AND METASTASIS REVIEWS
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- Epigenetic Modifications
- (2011) Diane E. Handy et al. CIRCULATION
- A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma
- (2011) T. K. Eigentler et al. CLINICAL CANCER RESEARCH
- A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma
- (2011) S. M. Rudman et al. CLINICAL CANCER RESEARCH
- Epigenetic modifications in cancer
- (2011) R Kanwal et al. CLINICAL GENETICS
- A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
- (2011) Katherine M. Bell-McGuinn et al. GYNECOLOGIC ONCOLOGY
- In Vivo Anti-Tumor Activity of Polypeptide HM-3 Modified by Different Polyethylene Glycols (PEG)
- (2011) Zhendong Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer
- (2011) Hiroyuki Yamamoto INTERNATIONAL JOURNAL OF ONCOLOGY
- Epigenetic cancer therapy: rationales, targets and drugs
- (2011) M Rius et al. ONCOGENE
- The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
- (2010) Manfred Johannsen et al. EUROPEAN JOURNAL OF CANCER
- Microarray-based Transcriptional and Epigenetic Profiling of Matrix Metalloproteinases, Collagens, and Related Genes in Cancer
- (2010) Andrei V. Chernov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The extracellular matrix at a glance
- (2010) C. Frantz et al. JOURNAL OF CELL SCIENCE
- The Collagen Family
- (2010) S. Ricard-Blum Cold Spring Harbor Perspectives in Biology
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- Proteoglycans: from structural compounds to signaling molecules
- (2009) Liliana Schaefer et al. CELL AND TISSUE RESEARCH
- The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands
- (2009) H. Takeshima et al. GENOME RESEARCH
- Aberrant DNA methylation of integrin α4: a potential novel role for metastasis of cholangiocarcinoma
- (2009) Kyung-Ok Uhm et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Regulation of 4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition
- (2009) X. Yang et al. JOURNAL OF CELL SCIENCE
- Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds 5 1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study
- (2008) A. D. Ricart et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now